Improving clinical outcomes with pembrolizumab in patients with advanced melanoma

Chin Clin Oncol. 2017 Feb;6(1):2. doi: 10.21037/cco.2017.01.04.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Humans
  • Melanoma*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab